0000819689-13-000058.txt : 20130919 0000819689-13-000058.hdr.sgml : 20130919 20130919153512 ACCESSION NUMBER: 0000819689-13-000058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130919 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20130919 DATE AS OF CHANGE: 20130919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ CENTRAL INDEX KEY: 0000819689 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 720925679 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09731 FILM NUMBER: 131105600 BUSINESS ADDRESS: STREET 1: 25 SAWYER PASSWAY CITY: FITCHBURG STATE: MA ZIP: 01420 BUSINESS PHONE: 978-345-5000 MAIL ADDRESS: STREET 1: 25 SAWYER PASSWAY CITY: FITCHBURG STATE: MA ZIP: 01420 8-K 1 a20130913resignationofpmul.htm 2013 09 19 RESIGNATION OF PMULDOON 2013 09 19 Resignation of PMuldoon


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549




FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported): September 13, 2013



Arrhythmia Research Technology, Inc.
(Exact name of registrant as specified in its charter)



Delaware
(State or other jurisdiction of Incorporation or organization)
1-9731
(Commission File Number)
72-0925679
(I.R.S. Employer Identification Number)

25 Sawyer Passway
Fitchburg, MA 01420
(Address of principal executive offices and zip code)

(978) 345-5000
(Registrant's telephone number, including area code)




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))









Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.

(b) Effective September 19, 2013, Mr. Patrick L. Muldoon, a Class III director, resigned as a member of Arrhythmia Research Technology, Inc. Board of Directors and the committees of the Board on which he served. The resignation was not a result of any disagreement with the Company’s Board or its management.
Mr. Muldoon determined that his professional obligations as the recently appointed president of UMass Memorial Medical Center in Worcester, Massachusetts required him to devote his time to his new endeavors.
The committees of the Board of Directors and its members, each of whom are independent, are, as a result of this change:

Executive and Finance Committee

E. P. Marinos
Dr. Paul F. Walter
Mr. Jason R. Chambers

Compensation Committee
        
Dr. Paul F. Walter (Chair)

        E. P. Marinos
Jason R. Chambers

Audit Committee

Jason R. Chambers (Chair)
E. P. Marinos

Nominating & Corporate Governance Committee
    
E. P. Marinos (Chair)
Dr. Paul F. Walter
Jason R. Chambers






SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fitchburg, Commonwealth of Massachusetts, on the 19th day of September, 2013.

ARRHYTHMIA RESEARCH TECHNOLOGY, INC.

By: /s/ Derek T. Welch
Derek T. Welch
Corporate Controller &
Principal Financial and Accounting Officer